Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Alaix Juan Ramon	2. Issuer Name and Ticker or Trading Symbol Zoetis Inc. [ ZTS ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle) C/O ZOETIS INC., 10 SYLVAN WAY	3. Date of Earliest Transaction (MM/DD/YYYY) 2/14/2020
(Street) PARSIPPANY, NJ 07054 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	2/14/2020		M			45073.9908	⁽²⁾	⁽²⁾	Common Stock	45073.9908	$0	64902.0496 ⁽³⁾	D
Deferred Stock Unit ⁽⁴⁾	⁽⁵⁾	2/14/2020		A		45073.9908		⁽²⁾	⁽²⁾	Common Stock	45073.9908	⁽²⁾	285705.2217	D
Performance Award Unit	⁽⁶⁾	2/14/2020		M			66772.2058	⁽⁷⁾	⁽⁷⁾	Common Stock	66772.2058	$0	0	D
Deferred Stock Unit ⁽⁴⁾	⁽⁵⁾	2/14/2020		A		66772.2058		⁽⁷⁾	⁽⁷⁾	Common Stock	66772.2058	⁽⁷⁾	352477.4275	D

Explanation of Responses:
(1)	Vesting of restricted stock units ("RSUs") granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.
(2)	Upon the vesting of the reporting person's restricted stock units on 2/14/2020, the reporting person received 45,073.9908 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis.
(3)	The RSUs vest as follows: 37,316.1003 RSUs will vest on February 13, 2021; and 27,585.9493 RSUs will vest on February 12, 2022.
(4)	Represents DSUs received pursuant to the Zoetis Equity Deferral Plan. DSUs are fully vested and are settled, together with dividend equivalent units automatically issued thereon, in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis.
(5)	Each DSU represents the right to receive one share of Zoetis Inc. common stock in accordance with the terms of the Zoetis Equity Deferral Plan.
(6)	Vesting of performance award units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.
(7)	Upon the vesting of the reporting person's performance award units on 2/14/2020, the reporting person received 66,772.2058 DSUs pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Alaix Juan Ramon C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY, NJ 07054	X